Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosus, Cutaneous”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Large-scale testing (Phase 3)Looking for participantsNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Early research (Phase 1)Ended earlyNCT01164917
What this trial is testing

Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus

Who this might be right for
Cutaneous LupusDiscoid LupusLupus+1 more
Amgen 16
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Large-scale testing (Phase 3)Not Yet RecruitingNCT06965244
What this trial is testing

Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
Assistance Publique - Hôpitaux de Paris 122
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Not applicableStudy completedNCT00633945
What this trial is testing

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)
University of Pennsylvania 5
Not applicableStudy completedNCT02125695
What this trial is testing

Pilot Tape Harvesting Study

Who this might be right for
Atopic DermatitisHealthyDiscoid Lupus Erythematosus+1 more
Biogen 37
Large-scale testing (Phase 3)Active Not RecruitingNCT06015737
What this trial is testing

A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus
AstraZeneca 306
Not applicableLooking for participantsNCT00512694
What this trial is testing

Duke Lupus Registry

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus
Duke University 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04857034
What this trial is testing

Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Subacute Cutaneous
Bristol-Myers Squibb 74
Early research (Phase 1)Study completedNCT03817424
What this trial is testing

Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more
Amgen 31
Testing effectiveness (Phase 2)Ended earlyNCT03958955
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Who this might be right for
Discoid Lupus Erythematosus
LEO Pharma 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06980805
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH 56
Early research (Phase 1)Study completedNCT04493541
What this trial is testing

Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Cutaneous
Bristol-Myers Squibb 13
Not applicableLooking for participantsNCT06551389
What this trial is testing

Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Brest 300
Testing effectiveness (Phase 2)Study completedNCT04908280
What this trial is testing

Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
University of Rochester 10
Testing effectiveness (Phase 2)Looking for participantsNCT06261021
What this trial is testing

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
Innovaderm Research Inc. 20
Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Testing effectiveness (Phase 2)Ended earlyNCT01466725
What this trial is testing

A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus
Celgene 5
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Load More Results